Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update

Quarter highlighted by steadily increasing patient demand for Vivos’ differentiated array of highly effective OSA treatments Management to Host Conference Call today at 5:00 pm ET <p...